Patients' views of consent for research enrollment during acute myocardial infarction

Neal W Dickert1, Alexandra E Fehr, Alex Llanos

  • 1Department of Medicine, Division of Cardiology, Emory University School of Medicine , Atlanta, GA , USA.

Acute Cardiac Care
|January 3, 2015
PubMed

Insights

Patients with ST-elevation myocardial infarction (STEMI) often struggle with informed consent due to their condition. While recognizing barriers, they value participation and wish to make decisions themselves.

Area of Science:

  • Cardiology
  • Clinical Trials
  • Informed Consent Research

Background:

  • Informed consent in ST-elevation myocardial infarction (STEMI) research is challenging due to acute conditions.
  • Time constraints, symptom severity, and cognitive impairment impact patient understanding.

Purpose of the Study:

  • To understand patient perspectives on informed consent during clinical trial enrollment for STEMI.
  • To identify challenges and preferences in the informed consent process for acute cardiac events.

Main Methods:

  • An embedded interview study using a structured guide was conducted within a STEMI clinical trial.
  • Twenty interviews were performed with patients post-procedure.

Main Results:

  • 55% of patients did not recall being asked to participate in a trial.
  • Patient comprehension of study details was limited; many perceived the intervention as clinically superior or mandatory.
  • Patients cited pain, stress, and time constraints as barriers but desired to be the primary decision-makers.

Conclusions:

  • Patients acknowledge understanding barriers in STEMI informed consent but value the consent process.
  • Future research should focus on consent approaches that respect patient autonomy within the acute STEMI context.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
502
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
483
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.9K
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
591
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
805
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
331